Advice You - Business

Dabbling Vs. Building- Interesting concept. Some people, and I am talking about l

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ots of people, do not know the exact roadmap to follow to produce maximum results

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

in a perfectly executed fashion. Thus dabbling is born.

Dabbling is the basis for

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

exploring other businesses and income models. If we all were expert marketers, so

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

me markets would not exist. Learning from experienced marketers, it is valuable fo

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

a person with less experience, period.

All ideas are learned from information ga

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

thered from experience. Any information is compiled from multiple sources in an in

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

dividuals own personal exposure in a given area. So a different perspective from a

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

individual using info that is not exactly new, but has had good experiences and h

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

as profited, can benefit any individual, because knowledge is the basis of communi

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ation, and communication is the foundation of commerce. Think about it.

Much of t

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

he current info on the net is rehashed hype and sales copy designed to grab a few

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

bucks from some gullible person who finds out that the product they purchased is n

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

t going to work for them, or that they need to buy additional products, and so on.

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

We have seen or heard about this.

It would be nice to be able to have a staff of

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

people working on expanding various aspects of the multiple avenues of wealth you

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

have created, webmasters, secretaries, copywriters, legal advisors, marketing expe

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

rts, etc.

Face it, you can’t start at the top. First you dabble, experiment. Seco

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

d, you focus and build. Third you, expand and profit in the areas that you are mo

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

st comfortable with and work the best for you.

Go ahead and dabble, Any questions

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/26448/adviceyou-Dabbling-Vs-Building.html">Dabbling Vs. Building</a>

BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/26448/adviceyou-Dabbling-Vs-Building.html]Dabbling Vs. Building[/url]

The quality of a lead has been debated for years and will continue to be debated for the foreseeable future...

There are many Six Sigma jobs in many industries at junior and senior levels. The demand for people with Six Sigma expertise is constantly increasing. The positions have descriptions and requirements unique to that organization and its requirements.

FROM the 'MORAL HIGH GROUND', where we imagine ourselves, the Enron fiasco should have come as no surprise. Enron is simply a quintessential example of the degradation of principles such as trust, l...

Tags

Links

Advice You - Dabbling Vs. Building

Related Articles: